Supply Issues Nissha Medical Technologies Ltd Bd Ultrasound Gel FDK1442 and FDK1433 (ICN 2456)

• The supply issue of Ultrasound Gel products from Nissha Medical Technologies Ltd Bd is continuing.
• One further product code is now suspended and unavailable to order:
  • FDK1433 – Ultrasound Gel.
• FDK1442 remains suspended and unavailable to order.
• Two product codes are now affected in total.
• Potential indirect alternative products are available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is now anticipated to be resolved by 15 April 2024.

Change:

• The supplier Nissha Medical Technologies Ltd Bd has informed us of a supply issue with its Ultrasound Gel products:
  • FDK1442 – Ultrasound Gel 20g, Sachet (sterile).
• The supply issue is due to increased demand and lead times.

Impact:

• FDK1442 is currently unavailable to order.
• Potential indirect alternative products are available to order through our online catalogue:
  • FDK1440 – Ultrasound Gel
  • FTM338 – Ultrasound Gel
  • FTM573 – Ultrasound Gel.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 29 March 2024.

Next Steps:              

• Customers are advised to log into our website to view the potential indirect alternative products.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.